NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways

Molecular Immunology

Volumn 45, Issue 15, 2008, Pages 3917-3925

  Verhoeven, Dirk H J ^a   de Hooge, Alfons S K ^a   Mooiman, Esther C K ^a   Santos, Susy Justo ^a   ten Dam, Monique M ^a   Gelderblom, Hans ^a   Melief, Cornelis J M ^a   Hogendoorn, Pancras C W ^a   Egeler, R Maarten ^a   van Tol, Maarten J D ^a   Schilham, Marco W ^a   Lankester, Arjan C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cellular immunotherapy; DNAM 1; Ewing sarcoma; NK cells; NKG2D

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; DNAM 1 RECEPTOR; HLA ANTIGEN CLASS 1; INTERLEUKIN 15; NATURAL KILLER CELL RECEPTOR NKG2D; UNCLASSIFIED DRUG;

ARTICLE; CANCER RELAPSE; CELL ACTIVATION; CELL COUNT; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; EWING SARCOMA; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; METASTASIS; NATURAL KILLER CELL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION;

ADOLESCENT; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BONE NEOPLASMS; CELL LINE, TUMOR; CHILD; CHILD, PRESCHOOL; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; SARCOMA, EWING'S; YOUNG ADULT;

EID: 49649119363     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2008.06.016     Document Type: Article

References (33)

1. Atzpodien J., Gulati S.C., Shimazaki C., Buhrer C., Oz S., Kwon J.H., Kolitz J.E., and Clarkson B.D. Ewing's sarcoma: ex vivo sensitivity towards natural and lymphokine-activated killing. Oncology 45 (1988) 437-443
2. Bernstein M., Kovar H., Paulussen M., Randall R.L., Schuck A., Teot L.A., and Juergens H. Ewing's sarcoma family of tumors: current management. Oncologist 11 (2006) 503-519
3. Bottino C., Castriconi R., Pende D., Rivera P., Nanni M., Carnemolla B., Cantoni C., Grassi J., Marcenaro S., Reymond N., Vitale M., Moretta L., Lopez M., and Moretta A. Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J. Exp. Med. 198 (2003) 557-567
4. Bryceson Y.T., March M.E., Ljunggren H.G., and Long E.O. Activation, coactivation, and costimulation of resting human natural killer cells. Immunol. Rev. 214 (2006) 73-91
5. Bryceson Y.T., March M.E., Ljunggren H.G., and Long E.O. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 107 (2006) 159-166
6. Burchill S.A. Ewing's sarcoma: diagnostic, prognostic, and therapeutic implications of molecular abnormalities. J. Clin. Pathol. 56 (2003) 96-102
7. Campadelli-Fiume G., Cocchi F., Menotti L., and Lopez M. The novel receptors that mediate the entry of herpes simplex viruses and animal alphaherpesviruses into cells. Rev. Med. Virol. 10 (2000) 305-319
8. Carayannopoulos L.N., and Yokoyama W.M. Recognition of infected cells by natural killer cells. Curr. Opin. Immunol. 16 (2004) 26-33
9. Carlsten M., Bjorkstrom N.K., Norell H., Bryceson Y., van Hall T., Baumann B.C., Hanson M., Schedvins K., Kiessling R., Ljunggren H.G., and Malmberg K.J. DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells. Cancer Res. 67 (2007) 1317-1325
10. Castriconi R., Dondero A., Corrias M.V., Lanino E., Pende D., Moretta L., Bottino C., and Moretta A. Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interaction. Cancer Res. 64 (2004) 9180-9184
11. Chin T., Toy C., Vandeven C., and Cairo M.S. Lymphokine-activated killer cytotoxicity in neonatal mononuclear cells: in vitro responses to tumor cell lines from pediatric solid tumors. Pediatr. Res. 25 (1989) 156-160
12. Costello R.T., Sivori S., Marcenaro E., Lafage-Pochitaloff M., Mozziconacci M.J., Reviron D., Gastaut J.A., Pende D., Olive D., and Moretta A. Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia. Blood 99 (2002) 3661-3667
13. Cotterill S.J., Ahrens S., Paulussen M., Jurgens H.F., Voute P.A., Gadner H., and Craft A.W. Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. J. Clin. Oncol. 18 (2000) 3108-3114
14. Coudert J.D., and Held W. The role of the NKG2D receptor for tumor immunity. Semin. Cancer Biol. 16 (2006) 333-343
15. Delattre O., Zucman J., Melot T., Garau X.S., Zucker J.M., Lenoir G.M., Ambros P.F., Sheer D., Turc-Carel C., and Triche T.J. The Ewing family of tumors-a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N. Engl. J. Med. 331 (1994) 294-299
16. Gasser S., and Raulet D. The DNA damage response, immunity and cancer. Semin. Cancer Biol. 16 (2006) 344-347
17. Hayakawa Y., and Smyth M.J. NKG2D and cytotoxic effector function in tumor immune surveillance. Semin. Immunol. 18 (2006) 176-185
18. Miller J.S., Soignier Y., Panoskaltsis-Mortari A., McNearney S.A., Yun G.H., Fautsch S.K., McKenna D., Le C., Defor T.E., Burns L.J., Orchard P.J., Blazar B.R., Wagner J.E., Slungaard A., Weisdorf D.J., Okazaki I.J., and McGlave P.B. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood 105 (2005) 3051-3057
19. Moretta L., Bottino C., Pende D., Castriconi R., Mingari M.C., and Moretta A. Surface NK receptors and their ligands on tumor cells. Semin. Immunol. 18 (2006) 151-158
20. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat. Rev. Immunol. 5 (2005) 201-214
21. Passweg J.R., Koehl U., Uharek L., Meyer-Monard S., and Tichelli A. Natural-killer-cell-based treatment in haematopoietic stem-cell transplantation. Best. Pract. Res. Clin. Haematol. 19 (2006) 811-824
22. Pende D., Spaggiari G.M., Marcenaro S., Martini S., Rivera P., Capobianco A., Falco M., Lanino E., Pierri I., Zambello R., Bacigalupo A., Mingari M.C., Moretta A., and Moretta L. Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the poliovirus receptor (CD155) and Nectin-2 (CD112). Blood 105 (2005) 2066-2073
23. Pogge von Strandmann E., Simhadri V.R., von Tresckow B., Sasse S., Reiners K.S., Hansen H.P., Rothe A., Boll B., Simhadri V.L., Borchmann P., McKinnon P.J., Hallek M., and Engert A. Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells. Immunity 27 (2007) 965-974
24. Raulet D.H. Roles of the NKG2D immunoreceptor and its ligands. Nat. Rev. Immunol. 3 (2003) 781-790
25. Reymond N., Imbert A.M., Devilard E., Fabre S., Chabannon C., Xerri L., Farnarier C., Cantoni C., Bottino C., Moretta A., Dubreuil P., and Lopez M. DNAM-1 and PVR regulate monocyte migration through endothelial junctions. J. Exp. Med. 199 (2004) 1331-1341
26. Ruggeri L., Capanni M., Urbani E., Perruccio K., Shlomchik W.D., Tosti A., Posati S., Rogaia D., Frassoni F., Aversa F., Martelli M.F., and Velardi A. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295 (2002) 2097-2100
27. Shibuya A., Campbell D., Hannum C., Yssel H., Franz-Bacon K., McClanahan T., Kitamura T., Nicholl J., Sutherland G.R., Lanier L.L., and Phillips J.H. DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity 4 (1996) 573-581
28. Shibuya A., Lanier L.L., and Phillips J.H. Protein kinase C is involved in the regulation of both signaling and adhesion mediated by DNAX accessory molecule-1 receptor. J. Immunol. 161 (1998) 1671-1676
29. Shibuya K., Lanier L.L., Phillips J.H., Ochs H.D., Shimizu K., Nakayama E., Nakauchi H., and Shibuya A. Physical and functional association of LFA-1 with DNAM-1 adhesion molecule. Immunity 11 (1999) 615-623
30. Staege M.S., Hansen G., Baersch G., and Burdach S. Functional and molecular characterization of interleukin-2 transgenic Ewing tumor cells for in vivo immunotherapy. Pediatr. Blood Cancer 43 (2004) 23-34
31. Szuhai K., IJszenga M., Tanke H.J., Rosenberg C., and Hogendoorn P.C. Molecular cytogenetic characterization of four previously established and two newly established Ewing sarcoma cell lines. Cancer Genet. Cytogenet. 166 (2006) 173-179
32. Szuhai K., IJszenga M., Tanke H.J., Taminiau A.H., de Schepper A., van Duinen S.G., Rosenberg C., and Hogendoorn P.C. Detection and molecular cytogenetic characterization of a novel ring chromosome in a histological variant of Ewing sarcoma. Cancer Genet. Cytogenet. 172 (2007) 12-22
33. Urano F., Umezawa A., Yabe H., Hong W., Yoshida K., Fujinaga K., and Hata J. Molecular analysis of Ewing's sarcoma: another fusion gene, EWS-E1AF, available for diagnosis. Jpn. J. Cancer Res. 89 (1998) 703-711